Researchers
Milosavljević, Filip
Type
Date issued
Results 1-20 of 29
| Issue Date | Title | Author(s) | Type | Мp-cat. |
|---|---|---|---|---|
| 2026 | Perceived stress four weeks after initiation of escitalopram monotherapy as a predictor of anxiolytic and antidepressant effects![]() | Vuković, Petar | Article | 21aM21a |
| 2025 | Effectiveness and safety of escitalopram treatment personalized based on therapeutic drug monitoring of drug plasma concentration: a prospective cohort study![]() | Vuković, Petar G. | Article | 21M21 |
| 2025 | CYP2C19 in the developing brain of transgenic humanized knock-in mouse causes morphological changes in the cerebellum![]() | Atanasov, Andrea | Conference Paper | Mp. category will be shown later |
| 2024 | Social adolescent stress causes increased general anxiety in male rats and decreased social anxiety in both sexes![]() | Manojlović, M.; Milosavljević, Filip | Conference Paper | Mp. category will be shown later |
| 2024 | Association between escitalopram dose personalisation based on quantification of drug plasma levels and the outcome of escitalopram treatment![]() | Vuković, Petar G.; Jeremić, Aleksandra | Conference Paper | Mp. category will be shown later |
| 2024 | Pharmacogenetic Variants and Plasma Concentrations of Antiseizure Drugs: A Systematic Review and Meta-Analysis | Milosavljević, Filip | Article | 21a+M21a+ |
| 2024 | Current level of evidence for improvement of antidepressant efficacy andtolerability by pharmacogenomic-guided treatment: A Systematic reviewand meta-analysis of randomized controlled clinical trials![]() | Milosavljević, Filip | Article | 21aM21a |
| 2024 | Living systematic review and meta-analysis of plasma-concentrations of antipsychotic drugs in carriers and non-carriers of variant CYP450 genotypes: Living systematic review protocol | Milosavljević, Filip | Article | 22M22 |
| 2024 | Social isolation during adolescence causes increased generalised anxiety-like behaviour in male rats and increased sociability in male and female rats | Manojlović, Marina | Article | Mp. category will be shown later |
| 2023 | The humanised CYP2C19 transgenic mouse exhibits cerebellar atrophy and movement impairment reminiscent of ataxia | Milosavljević, Filip | Article | 21aM21a |
| 2022 | CYP2C19 slow metabolizer phenotype is associated with lower antidepressant efficacy and tolerability![]() | Joković, Danilo; Milosavljević, Filip | Article | 21a+M21a+ |
| 2022 | Social adolescent stress causes increased general anxiety in male rats and reduced social anxiety in both male and female rats | Manojlović, Marina | Conference Paper | Mp. category will be shown later |
| 2022 | CYP2C19 slow metabolizer phenotype is associated with lower antidepressant efficacy and tolerability: clinical study on 102 inpatients![]() | Joković, Danilo; Milosavljević, Filip | Conference Paper | Mp. category will be shown later |
| 2022 | Meta-analiza podataka o razlikama u izloženosti psihijatrijskim lekovima između sporih i normalnih CYP2C19/CYP2D6 metabolizera![]() | Milosavljević, Filip | Doctoral theses | 70M70 |
| 2022 | Hepatocyte Thorns, A Novel Drug-Induced Stress Response in Human and Mouse Liver Spheroids | Pridgeon, Chris; Bolhuis, Dian; Milosavljević, Filip | Article | 21M21 |
| 2022 | Patients’ and psychiatrists’ stance on the current state of pharmacological depression treatment in Serbia and prospects of introduction of personalized pharmacotherapy and its potential effects | Jeremić, Aleksandra | Article | 52M52 |
| 2022 | Humanized CYP2C19 transgenic mouse as an animal model of cerebellar ataxia![]() | Milosavljević, Filip | Conference Paper | Mp. category will be shown later |
| 2022 | Association between CYP2C19 genotype and body weight with escitalopram exposure – a cross sectional study![]() | Jeremić, Aleksandra | Conference Paper | Mp. category will be shown later |
| 2022 | Pharmacogenomics in treatment of depression and psychosis: an update | Jukić, Marin | Article | 21a+M21a+ |
| 2022 | Effects of personalized dosing based on drug plasma level quantification on effectiveness and safety of escitalopram treatment![]() | Vuković, Petar | Conference Paper | Mp. category will be shown later |
